- Home
- VIOT vs VRCA Comparison
VIOT vs VRCA Comparison
Compare VIOT & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VIOT | VRCA |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.1M | 88.0M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | VIOT | VRCA |
|---|---|---|
| Price | $1.30 | $3.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $13.83 |
| AVG Volume (30 Days) | ★ 417.4K | 51.9K |
| Earning Date | 08-27-2026 | 11-13-2026 |
| Dividend Yield | ★ 4.71% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $35,577,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.78 | $58.01 |
| P/E Ratio | $3.56 | ★ N/A |
| Revenue Growth | N/A | ★ 370.22 |
| 52 Week Low | $0.66 | $3.28 |
| 52 Week High | $3.53 | $9.82 |
Technical Indicators
Market Signals| Indicator | VIOT | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 46.54 | 37.19 |
| Support Level | $1.20 | N/A |
| Resistance Level | $1.50 | $5.94 |
| Average True Range (ATR) | 0.12 | 0.35 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 12.77 | 24.32 |
Price Performance
Historical ComparisonAbout VIOT Viomi Technology Co. Ltd
Viomi Technology Co Ltd, along with its subsidiaries, specializes in the development and sale of Internet-of-Things-enabled smart home products, particularly focusing on home water solutions. The company markets its products in China and generates the majority of its revenue through the sale of smart water purification systems and other connected home devices designed to improve convenience and automation in residential settings. Its product offerings include water purification products, water heaters, smart water kettles, electric kettles, water filters, range hoods, gas stoves, and other small appliances.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.